| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.85B | +18.0% |
| Cost of Revenue | $580.2M | +12.7% |
| R&D Expense | $747.2M | +0.1% |
| SG&A Expense | $1.01B | +7.7% |
| Operating Income | $484.2M | +206.3% |
| Pre-tax Income | $541.8M | +187.3% |
| Income Tax | $114.9M | +449.3% |
| Net Income | $426.9M | +154.6% |
| EPS (Basic) | $2.25 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $942.8M | +24.9% |
| Accounts Receivable | $660.5M | +4.2% |
| Inventory | $1.23B | +11.3% |
| Current Assets | $3.23B | +9.3% |
| Total Assets | $6.99B | +2.2% |
| Current Liabilities | $607.0M | -48.4% |
| Total Liabilities | $1.33B | -29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $572.8M | +259.7% |
| Capital Expenditures | $85.4M | -11.7% |
| Investing Cash Flow | $136.5M | +222.7% |
| Financing Cash Flow | -$526.4M | -2711.2% |
| Free Cash Flow | $487.4M | +679.0% |
| +152.8% |
| EPS (Diluted) | $2.21 | +154.0% |
| Stockholders' Equity |
| $5.66B |
| +14.3% |